Donnerstag, 27.01.2022 19:10 von GlobeNewswire | Aufrufe: 436

Generix Group - Third Quarter Revenue 2021 / 2022: €20.5 M, in line with latest forecasts

Zeitungsständer (Symbolbild). © AdrianHancu / iStock Editorial / Getty Images Plus / Getty Images

PRESS RELEASE

Paris, January 27, 2022

Q3 2021/2022 revenues: 20.5 M, in line with latest forecasts

New SaaS contracts Q3 2021/2022: 1.4 M

Confirmation of financial objectives for the year

Generix Group, Industrial, Logistics and Retail Ecosystems provider with leading Collaborative SaaS Solutions, publishes today its revenues for the third quarter of the 2021/2022 fiscal year.

Q3 revenues: €20.5 million (-0.9%)

 

  Trimestre clos
le 31 décembre
Variation  9 mois clos
le 31 décembre
Variation
Non audité (K€) 2021 2020 2021 2020
SaaS                          8 531                             8 375 2%                            25 193                            24 071 5%
Maintenance                          4 771                             4 512 6%                            13 994                            13 489 4%
Licences                             711                                974 -27%                              3 253                              2 834 15%
Activités d'Edition                        14 013                           13 861 1,1%                            42 440                            40 394 5,1%
Conseil & Services                          6 531                             6 875 -5%                            19 580                            18 442 6%
Chiffre d'Affaires                        20 544                           20 736 -0,9%                            62 020                            58 836 5,4%


 

Kurse

  
9,38
-0,64%
GENERIX GROUP Chart

 

Revenues for the past quarter amounted to €20.5 million, down 0.9% compared to Q3 of the previous year. As a result, revenue growth was +5.4% for the first nine months of the year. 
 

As announced at the time of the presentation of the half-year results, the Group is experiencing a temporary slowdown in its sales of Licenses, Consulting & Services in North America. This trend, which began at the end of the second quarter, has led the Group to replace the Managing Director of this Business Unit, which has enabled the commercial indicators to be revived. The return to a normal level of activity should be achieved during the first half of the next fiscal year.

New SaaS contracts Q3: 1.4 M (+2.3%)

  Quarter ended December 31 Change 9 months ended December 31 Change
Unaudited (K€) 2021 2020 2021 2020
New SaaS contract signing (ACV*) 1 380 1 349 2,3% 3 717 2 530 46,9%

 * New signatures expressed in ACV (Annual Contract Value) highlighting the average annual additional revenue that will be generated after deployment of the contracts concerned.

As a reminder, in the previous year, the health crisis led to a slowdown in new SaaS contract signatures over the first six months, followed by an acceleration in the second half of the year.

With an additional growth of 2.3% compared to Q3 of the previous fiscal year, the growth of signatures during the first 9 months of the fiscal year amounts to +46.9%.

The last 12 consecutive months are among the Group's highest levels of signatures ever, amounting to €5.9 million.

Among these new signatures, it is worth noting:

  • the signature in North America of a major player in the distribution of spare parts for automobiles, which has chosen Generix Group's Solochain WMS solution to manage its warehouse, which benefits in particular from a new ASRS (Automated Storage and Retrieval System) with which the Generix solution will be interfaced. The ability of Generix's solution to connect to these new warehouse technologies has been a real asset.

  • a new Italian customer, an international packaging supplier who has chosen the Generix Group Warehouse Management System (WMS), Transport Management System (TMS) and Supply Chain Visibility solutions for 19 warehouses in 2 countries in its EMEA zone.

These contracts confirm Generix Group's ability to win the trust of major players throughout the supply chain.

Confirmation of financial objectives for the year

Generix Group confirms the outlook announced at the time of the presentation of its half-yearly financial statements: growth that is a few points lower than the double-digit growth previously expected and comparable to that recorded over the first nine months of the year.

The signing dynamic remains at high levels and should continue over the at the end of the year.

The Group maintains its forecast of a stable EBITDA margin compared to the previous fiscal year, with a sustained policy of investment in R&D, and in Sales and Marketing to capture market growth.

Supplemental and non-IFRS Financial Information

Supplemental non-IFRS information (above-mentioned as EBITDA) presented in this press release is subject to inherent limitations. It is not based on any comprehensive set of accounting rules or principles and should not be considered as a substitute for IFRS measurements. Also, the Company’s supplemental non-IFRS financial information may not be comparable to similarly titled non-IFRS measures used by other companies.

Next financial press release: April 26th, 2022, after market closes

Publication of the yearly revenue

About Generix Group

Generix Group is a Collaborative Supply Chain expert present in 60 countries, thanks to its subsidiaries and network of partners. More than 6,000 companies around the world use its SaaS solutions. The group’s 800 employees provide daily support for such customers as Carrefour, Danone, FM Logistic, Fnac-Darty, Essilor, Ferrero and Geodis in the digital transformation of their Supply Chain.

Its collaborative platform, Generix Supply Chain Hub, helps companies to keep the promises they make to their customers. It combines the capabilities to execute physical flows, digitalize information flows, manage collaborative processes and connect companies to all their partners, in real time.

Generix Supply Chain Hub is aimed at all players in the Supply Chain: manufacturers, third- and fourth-party logistics providers (3PL/4PL) and retailers.

Founded in France in 1990, the company is listed on the Eurolist market of Euronext Paris, compartment C (ISIN: FR0010501692). To learn more: www.generixgroup.com

 

Attachment


Mehr Nachrichten zur Petro Welt Technologies Aktie kostenlos abonnieren

Werbung
E-Mail-Adresse
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptieren Sie die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.

Andere Nutzer interessierte auch dieser Artikel: